NanoString Technologies, Inc. (NSTGQ)
| Previous Close | 0.1075 |
| Open | 0.1074 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.0700 - 0.1111 |
| 52 Week Range | 0.0400 - 8.8200 |
| Volume | |
| Avg. Volume | 3,184,182 |
| Market Cap | 4.764M |
| Beta (5Y Monthly) | 0.28 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | Aug 01, 2024 - Aug 05, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 0.25 |
Business WireNational Geographic Magazine Showcases NanoString’s Spatial Biology Technology to Examine Cell Death in Alzheimer’s Disease
SEATTLE, March 27, 2024--NanoString Technologies, Inc. (OTC: NSTGQ), a leading provider of life science tools for discovery and translational research, today announced that research using the company’s CosMx™ Spatial Molecular Imager (SMI) has been featured for a third time in National Geographic Magazine.
Business WirePatient Square Capital, a Leading Health Care-Focused Investment Firm, Agrees to Acquire NanoString Technologies
SEATTLE, March 11, 2024--NanoString Technologies, Inc. (OTC: NSTGQ) ("NanoString" or the "Company"), a leading provider of life science tools for discovery and translational research, today announced that it has reached an agreement with Patient Square Capital ("Patient Square"), a prominent health care investment firm, pursuant to which Patient Square will serve as the "stalking horse" bidder in conjunction with a court-supervised sales process.
